Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04665115
Brief Title: Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)

First Submitted : December 10, 2020
First Submitted that Met QC Criteria : December 10, 2020
First Posted : December 11, 2020

Last Update Submitted that Met QC Criteria : January 20, 2021
Last Update Posted : January 22, 2021